"I know breakthrough is coming, By faith I see a miracle
My God made me a promise, And it won't stop now"
biotecHOPE™ Won’t Stop Now
My first post on the virus was on January 11, 2020. On August 1, 2020 I started the third full page of information and updates on Covid-19/SARS CoV2 at my site here= https://seekingbiotechalpha.com/biohaz-3 . I never thought that the BioHazard2020 would result in a third page, but it does. It is hard to believe that six months later America and the world is only now in an improving situation with this virus- Covid-19/SARS CoV2. The US Federal response has been severely lacking and under-performing. Administration officials are at odds with their own scientists, leaving the States to deal with most aspects of the virus on their own. And as the Feds stockpile PPE, state supplies remain in short supply.
Nearly everyone dying of Covid-19 has concurrent health problems—the average decedent has 2.5 co-morbid conditions—and hypertension, heart disease, respiratory diseases, and diabetes are among the most common. The presence and interaction of these co-morbid conditions is what sometimes changes Covid-19 from a relatively benign disease into a killer. But co-morbidities can also cause death regardless of Covid-19.
Coronavirus Drug and Treatment Tracker
"The country behaved like a horror-movie character who believes the danger is over, even though the monster is still at large." Despite ample warning, the U.S. squandered every possible opportunity to control the coronavirus. And despite its considerable advantages—immense resources, biomedical might, scientific expertise—it floundered.
How the Pandemic Defeated America
Fighting the Coronavirus, from New York to Utah
How the Pandemic Has Changed Us Already
Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China
CDC chief says coronavirus cases may be 10 times higher than reported
Actual Covid-19 case count could be 6 to 24 times higher, per CDC study
How Covid Sends Some Bodies to War With Themselves
Teladoc Health and Livongo Merge to Create New Standard in Global Healthcare Delivery, Access and Experience
Statistics Show the Deadly Cost of Lockdown Policies | City Journal
The Uncertainties Facing New York City's Young Essential Workers
https://www.nejm.org/doi/full/10.1056/NEJMoa2022483?query=featured_home
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
Christ the Redeemer reopens in Rio after months of coronavirus closures
Covid-19 Vaccine Progress & The Positive
Nevertheless there is encouraging news coming from biotech/pharma companies with regard to vaccines and therapies to fight this virus. And fortunately, there is hope and clinical trials are in progress on numerous vaccines for COVID-19, aka the www.BioHazard2020.com – The NY Times has a vaccine tracker here = Coronavirus Vaccine Tracker this is an excellent recap on the progress and types of vaccines that are in development/testing.
Although I do not make biotech/pharma picks based on vaccine development, I lean more toward cancer focused products, as vaccines are usually not profit oriented = EXCLUSIVE-Vaccine alliance eyes range of prices for COVID shots, says $40 would be maximum I do see many positive and encouraging things occurring with some vaccines based on the data from (PFE) (BNTX) (AZN) (MRNA) (NVAX) (JNJ) (GSK) (SNY). Many of these companies were already in my portfolio prior to the virus and I remain invested in them.
Pfizer-BioNTech favored Covid-19 vaccine has fewer side effects - STAT
Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging
Pfizer/BioNTech COVID-19 vaccine continues to show strong effect in early-stage study (NYSE:PFE)Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
Pfizer and BioNTech to Supply Canada with their BNT162 mRNA- Based Vaccine Candidate
Pfizer and BioNTech to Supply Canada with their BNT162 mRNA-Based Vaccine Candidate | BioNTech
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate
Global COVID-19 vaccine development program Lightspeed
Pfizer CEO Bourla on coronavirus vaccine timeline
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
AstraZeneca closes COVID-19 vaccine supply deal in Europe (NYSE:AZN)
Russia approves trial of AstraZeneca COVID-19 vaccine: registry filing
Production of AstraZeneca COVID-19 vaccine in Latin America to launch early 2021 (NYSE:AZN)Trump reportedly considers fast tracking AstraZeneca vaccine before election
Emergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate
A Study of a Candidate COVID-19 Vaccine (COV001) - Full Text View - ClinicalTrials.govCoronavirus vaccine hopes rise after strong trial results
Moderna to Present New Interim Clinical Data About mRNA Vaccine Against COVID-19 (mRNA-1273) at Advisory Committee on Immunization Practices (ACIP) Meeting
ACIP Meetings Information | CDC
Moderna to Present New Interim Clinical Data About mRNA Vaccine Against COVID-19 (mRNA-1273) at Advisory Committee on Immunization Practices (ACIP) Meeting | Moderna, Inc.Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein
Moderna's Work on a COVID-19 Vaccine Candidate
https://www.nejm.org/doi/full/10.1056/NEJMoa2024671?query=featured_coronavirus
Moderna COVID-19 vaccine shows robust effect in preclinical study (NASDAQ:MRNA)
https://www.nejm.org/doi/full/10.1056/NEJMoa2022483?query=featured_home
Moderna's mRNA Clinical Trials: CMV, MMA, Zika, Several Types of
Moderna says its coronavirus vaccine shows promising results in small trial of elderly patients
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax' COVID-19 Vaccine Candidate
Novavax to supply 60M COVID-19 vaccine doses to UK (NASDAQ:NVAX)
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Clinical Stage Pipeline - Novavax - Creating Tomorrow’s Vaccines Today. Novavax.com
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
CanSino Coronavirus Vaccine Shows Promise in Mid-Stage Study
Two More Covid-19 Vaccine Candidates to Start Human Trials in China
Vaccine-Maker CanSino's Stock Jumps Nearly 88% in STAR Market Debut
WSJ News Exclusive | For Covid-19 Vaccine, J&J Plans 60,000-Subject Pivotal Trial
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
Johnson & Johnson's Coronavirus Vaccine Protects Monkeys, Study Finds
J&J COVID-19 vaccine candidate shows positive effect in primate study; shares gain premarket (NYSE:JNJ)4 Latest Facts About Johnson & Johnson's Investigational COVID-19 Vaccine
J&J's COVID vaccine protected primates with single shot - BNN Bloomberg
Sanofi, GSK to supply 300M COVID-19 vaccine doses to EU (NASDAQ:SNY)
Sanofi: Press Releases, Friday, July 31, 2020
Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine
Sanofi/Glaxo join Operation Warp Speed, to supply 100M COVID-19 vaccine doses to U.S. (NASDAQ:SNY)Sanofi: Press Releases, Friday, July 31, 2020
Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine
Sanofi: Press Releases, Friday, July 31, 2020
Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial
Sinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCE
Sinovac COVID-19 vaccine shows positive effect in preclinical study (NASDAQ:SVA)R&D Strategy-SINOVAC - Supply Vaccines to Eliminate Human Diseases
Please keep in mind that any vaccine can help people fight a virus, but they are not 100% effective.
Vaccine Effectiveness: How Well Do the Flu Vaccines Work?
Bill Gates - the vaccine interview
And the creation of vaccines will present other issues highlighted in this Bloomberg article = The pharmaceutical industry cannot produce enough vaccine for the entire global population of almost 8 billion all at once. Therefore, rationing is inevitable. Some people will have to wait. Who gets to make these decisions, and by what criteria?
Coronavirus vaccine makers seek EU liability protections (NYSE:AZN)And will people get the vaccine? = The long wait for a vaccine will likely culminate in a predictable way: Many Americans will refuse to get it, and among those who want it, the most vulnerable will be last in line We shall see.
COVID-19 & Therapies - The Positive
Gilead's Remdesivir still leads as the most effective therapy for Covid-19 patients. (GILD) Merck is joining the race with = (MRK), Merck & Co. joins race for COVID-19 vaccines and therapies and CytoDyn (OTCQB:CYDY) is testing their med = leronlimab.
There are more companies testing other products which can be found here - www.biotecHOPE.com
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19
Health Canada Grants Marketing Authorization with Conditions (NOC/c) for Gilead's Veklury® (Remdesivir) for the Treatment of Coronavirus Disease 2019 (COVID-19)
CytoDyn Reaches Enrollment of 195 Patients in its Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms
CytoDyn Announces Clinically Significant Top-line Results from its Phase 2 Trial in Mild-to-Moderate COVID-19 Patients
CytoDyn announces "positive" results from mid-stage COVID-19 study (OTCMKTS:CYDY)
BiotecHOPE
There are many new medicines in testing, development and clinical trials that are currently not available to the marketplace and many are having encouraging and positive results. BiotecHOPE™ will seek to highlight these trials/efforts many of which are from smaller biotech companies and/or are being developed by Universities or Hospitals. Welcome to BiotecHOPE™ and thank you for visiting www.biotechope.com.
Won't Stop Now
I know breakthrough is coming By faith I see a miracle My God made me a promise And it won't stop now I know breakthrough is coming By faith I see a miracle My God made me a promise And it won't stop now I know breakthrough is coming By faith I see a miracle My God made me a promise And it won't stop now I know breakthrough is coming By faith I see a miracle My God made me a promise And it won't stop now
Come on, if you believe in the breakthrough And you know all things are possible with God Lift your arms Yes, oh
Source: LyricFind Songwriters: Chris Brown / Steven Furtick
Won't Stop Now lyrics © Essential Music Publishing
Won't Stop Now feat. Brandon Lake | Live | Elevation Worship Jul 20, 2020
Today August 26, 2020 I remain 100% invested in companies that develop products that improve and save lives. " I know breakthrough is coming"
Disclosure: I am/we are long the following companies (GILD) (AMGN) (JNJ) (ABBV) (BMY) (AZN) (MRK) (LLY) (PFE) (BMRN) as of 8/26/2020. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.
I am considering/reviewing adding the following to the seekingbiotechalpha portfolio (MRNA) (AMRN) (VIR) (ISRG) (MDT) (OTCQX:RHHBY) (TMO) (BNTX) (IMMU) (GSK) (SNY) (BGNE) (OTCPK:WXXWY) (ABT) (NVS) (ABMD) (SGEN) (NVO) (DXCM)
seekingbiotechalpha.com | danwatson888's Portfolio on GuruFocus.com
Respectfully submitted to Seeking Alpha on 8/26/2020.
GLTA
Dan Watson
https://seekingbiotechalpha.com/
